RGC (Regencell Bioscience Holdings) Total Stockholders Equity: $1.22 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

RGC Regencell Bioscience Holdings Ltd RGC
30 GF Score
Price $6.18
! 2 Warning Signs
View Full Analysis

What is Regencell Bioscience Holdings Total Stockholders Equity?

Regencell Bioscience Holdings RGC +4.04% 30 Total Stockholders Equity is $1.22 Mil as of Dec. 2025. GuruFocus rates RGC with a GF Score™ of 30/100. The stock has 2 warning signs investors should review.

Regencell Bioscience Holdings's Total Stockholders Equity for the quarter that ended in Dec. 2025 was $1.22 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Regencell Bioscience Holdings's Book Value per Share for the quarter that ended in Dec. 2025 was $0.00. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Regencell Bioscience Holdings's Debt-to-Equity for the quarter that ended in Dec. 2025 was 0.00.

Regencell Bioscience Holdings  (NAS:RGC) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Regencell Bioscience Holdings's Book Value per Share for the quarter that ended in Dec. 2025 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(1.219-0)/494.489
=0.00

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Regencell Bioscience Holdings's Debt-to-Equity for the quarter that ended in Dec. 2025 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0 + 0) / 1.219
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Regencell Bioscience Holdings Total Stockholders Equity Related Terms

Regencell Bioscience Holdings Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Regencell Bioscience Holdings's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Regencell Bioscience Holdings Total Stockholders Equity Chart

Regencell Bioscience Holdings Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Total Stockholders Equity
Get a 7-Day Free Trial -4.00 17.07 12.03 8.22 4.86

Regencell Bioscience Holdings Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.20 8.22 6.72 4.86 1.22
RGC
30GF Score
Regencell Bioscience Holdings Ltd RGC
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of $1.22 Mil mean?
Regencell Bioscience Holdings (RGC) has a Total Stockholders Equity of $1.22 Mil as of Dec. 2025. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Regencell Bioscience Holdings and its competitors.
Is Regencell Bioscience Holdings' Total Stockholders Equity too high?
Regencell Bioscience Holdings' current Total Stockholders Equity is $1.22 Mil. Overall, Regencell Bioscience Holdings has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Regencell Bioscience Holdings' Total Stockholders Equity compare to SUPN and BCRX?
Regencell Bioscience Holdings' Total Stockholders Equity of $1.22 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Drug Manufacturers company?
A good Total Stockholders Equity depends on the Drug Manufacturers industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Regencell Bioscience Holdings and its competitors. Regencell Bioscience Holdings's current Total Stockholders Equity is $1.22 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Regencell Bioscience Holdings stock overvalued right now?
Regencell Bioscience Holdings (RGC) has a current Total Stockholders Equity of $1.22 Mil. The current Total Stockholders Equity is $1.22 Mil. Regencell Bioscience Holdings' overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Regencell Bioscience Holdings (RGC), the current Total Stockholders Equity is $1.22 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Regencell Bioscience Holdings Business Description

Address 29 Leighton Road, 9th Floor, Chinachem Leighton Plaza, Causeway Bay, Hong Kong, HKG
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
30GF Score

Get the complete analysis for RGC

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.18
Price